Evidence map›Paper›PMID 36422635›Full record

ArticlePathogens (Basel, Switzerland)2022

Differential Impact of Specific Amino Acid Residues on the Characteristics of Avian Influenza Viruses in Mammalian Systems.

Dayly Mashaal, Sara H Mahmoud, Christin Müller, Noura M Abo Shama, Amal Abo Kamer, Ahmed A Abdelaziz, Mohamed A Ali, Stephan Pleschka, Ahmed Mostafa

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Dayly MashaalPharmaceutical Microbiology Department, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.
Sara H MahmoudCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.
Christin MüllerInstitute of Medical Virology, Justus Liebig University Giessen, Schubertstrasse 81, 35392 Giessen, Germany.ORCID 0000-0002-6444-9478
Noura M Abo ShamaCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.
Amal Abo KamerPharmaceutical Microbiology Department, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.
Ahmed A AbdelazizPharmaceutical Microbiology Department, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.
Mohamed A AliCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.ORCID 0000-0002-5615-3212
Stephan PleschkaInstitute of Medical Virology, Justus Liebig University Giessen, Schubertstrasse 81, 35392 Giessen, Germany.ORCID 0000-0002-7372-7089
Ahmed MostafaCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.ORCID 0000-0002-2878-5714
National Research Centre · EGTanta University · EGJustus-Liebig-Universität Gießen · DE

Funding

German Center for Infection Research FF 01.901German Center for Infection Research TTU 01.806National Research Centre TT110801 and 12010126
6 · The paper itself

Abstract

Avian influenza virus (AIV) H9N2 was declared to be endemic in birds of the Middle East, in particular in Egypt, with multiple cases of human infections. Despite concerns about the pandemic threat posed by H9N2 AIV, due to the fact that its receptor specificity is similar to that of human influenza viruses, its morbidity and mortality rates in humans are so far negligible. However, the acquisition of specific adaptive amino acid (aa) mutations in the viral polymerase can enhance cross-species transmission of the virus itself or of reassortants, which gained these changes. The polymerase basic protein 2 (PB2) is one of the key determinants for AIV adaptation towards mammals. Although mammalian pathogenicity-related mutations (MPMs) in PB2 genes were identified in different AIVs, the specific effect of single or multiple mutations on viral fitness has not been compared so far. Here, we studied the effect of the aa K at position 591, which was frequently reported in the PB2 of Egyptian H9N2 isolates, on the proliferation efficiency and polymerase activity of an H5N1 (clade 2.2.1.2) AIV already carrying the mammalian adaptive mutation 627K. Using reverse genetics, we generated a set of recombinant parental strains and H5N1 variants carrying the avian-like 591Q/627E or mammalian-like adaptive mutations 591K/627K (H5N1

Indexed as

591K627KH5N1H9N2mammalian-adaptive marker

Identifiers

PMID36422635
PMCPMC9698692
OpenAlexW4309711332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.